GEMINI THERAPEUTICS Trademark

Trademark Overview

On Thursday, June 30, 2016, a trademark application was filed for GEMINI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the GEMINI THERAPEUTICS trademark a serial number of 87089478. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 12, 2024. This trademark is owned by Gemini Therapeutics, Inc.. The GEMINI THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the fields of biotechnology, pharmaceuticals, and new therapeutics all relating to ophthalmology
gemini therapeutics

General Information

Serial Number87089478
Word MarkGEMINI THERAPEUTICS
Filing DateThursday, June 30, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 12, 2024
Registration Number5370962
Registration DateTuesday, January 2, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2016

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesResearch and development in the fields of biotechnology, pharmaceuticals, and new therapeutics all relating to ophthalmology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 12, 2024
Primary Code042
First Use Anywhere DateTuesday, October 17, 2017
First Use In Commerce DateTuesday, October 17, 2017

Trademark Owner History

Party NameGemini Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameGemini Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameGemini Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 4, 2016NEW APPLICATION ENTERED
Tuesday, November 29, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 11, 2016ASSIGNED TO EXAMINER
Tuesday, October 11, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 11, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, October 11, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 11, 2016EXAMINER'S AMENDMENT ENTERED
Sunday, October 23, 2016ASSIGNED TO LIE
Thursday, October 27, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 22, 2017SOU EXTENSION 1 FILED
Thursday, June 22, 2017SOU EXTENSION 1 GRANTED
Monday, November 6, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 22, 2017SOU TEAS EXTENSION RECEIVED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 23, 2017TEAS STATEMENT OF USE RECEIVED
Monday, October 23, 2017USE AMENDMENT FILED
Monday, November 6, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 2, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 12, 2024CANCELLED SEC. 8 (6-YR)
Monday, November 27, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 28, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

therapeutics gemini relating ophthalmology pharmaceuticals biotechnology development fields research